Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation

Star of life medical symbol Bruce V. Bigelow

The significance of a deal announced last week during the 2015 International CES in Las Vegas went largely unnoticed amid the hubbub of the world’s biggest consumer (Read more...)

Even When Money is Easy, Rules of Biotech Finance Still Apply

Standish Fleming

Last month Juno Therapeutics closed a $250 million IPO, bringing the total raised since it was founded in Seattle in 2013 to close to $600 million. The (Read more...)

Hepatitis C Commercial Game Theory

Peter Kolchinsky

Anyone either celebrating or fearing the start of a Hepatitis C drug price war should take a break from the excitement to consider that a far more nuanced (Read more...)

Rethinking Venture Philanthropy After the Kalydeco Windfall

Peter Kolchinsky

The Cystic Fibrosis (CF) Foundation’s big win in venture philanthropy can fuel constructive competition among companies developing innovative CF drugs, benefiting both patients and the healthcare system by (Read more...)